Perfil de sensibilidad de S. agalactiae obtenido a partir de muestras de introito vaginal y región perineal de mujeres gestantes de Medellín (Colombia)

Clara María Duque Restrepo; Diana Marcela Sánchez; Olga Lucia Uribe

doi:10.22490/24629448.486

Vol. 9 No. 15 (2011)

Published

2011-06-15

PDF (Spanish)

How to Cite

Duque Restrepo, C. M., Sánchez, D. M., & Uribe, O. L. (2011). the susceptibility profile of S. agalactiae isolated from vaginal cavity and perineal region from pregnant women in Medellín (Colombia). NOVA Biomedical Sciences Journal, 9(15), 31-34. https://doi.org/10.22490/24629448.486

Download Citation

Metrics

Metrics Loading ...

the susceptibility profile of S. agalactiae isolated from vaginal cavity and perineal region from pregnant women in Medellín (Colombia)

DOI: https://doi.org/10.22490/24629448.486

Section

Research Article (before OJS)

Clara María Duque Restrepo Institución Universitaria Colegio Mayor de Antioquia

Diana Marcela Sánchez Institución Universitaria Colegio Mayor de Antioquia

Olga Lucia Uribe Institución Universitaria Colegio Mayor de Antioquia

We have carried out a descriptive study to determine the susceptibility profile of S. agalactiae isolates from the vaginal cavity and the perineal region from pregnant women in Medellín, between 2008 and 2010. The S. agalactiae isolates were obtained by first culturing samples in Todd Hewitt broth with antibiotics followed by sub-culturing in agar with Blood 5%. The Kirby-Bauer method described by the Clinical and Laboratory Standards Institute (CLSI) was used to evaluate the antimicrobial susceptibility profile of the isolates. A susceptibility of 100% to ampicillin and vancomycin was observed, that decreased to 25% for tetracycline and 72% for erythromycin and clindamycin.

S. agalactiae, susceptibility profile, MLSB mechanism.

RajagopalL.Understanding the regulation of Group B Streptococcal virulence factors. Future Microbiol. 2009 Mar; 4(2):201-21.

RJ, Baquero D. Frecuencia de aislamiento de Streptococcusagalactiaeen un grupo de embarazadas y sus productos. IATREIA. 1989;2:111-3.

González CP, González JE. Prevalencia de estreptococo beta hemolítico en mujeres embarazadas de alto riesgo en el Hospital Simón Bolívar de Bogotá. UCIN. 2001;2:7-15.

Miranda J, Sánchez I, Matar S. Detección de Streptococcusagalactiae en mujeres embarazadas del hospital San Jerónimo de Montería. InfQuincEpidemiolNac. 2002;7:

Restrepo A, Serna L, Vanegas C, Sarria C, Durango H, Zapata C. Prevalencia de Streptococcusagalactiae en gestantes con factores de riesgo y sus recién nacidos. Hospital Universitario San Vicente de Paúl, 2002. Infectio. 2003;7:147-52.

Duque CM, Gómez B, Uribe OI, et. al. Comparación de métodos para la recuperación y determinación de la prevalencia de Streptococcusagalactiae en mujeres gestantes de Medellín. Infectio. 2010; 14(2): 105-111

Di Bartolomeo S., Gentile M., Priore G., Valle S., Di Bella A..Streptococcus agalactiae en embarazadas. 2005 , 37: 142-144.

Clinical and Laboratory Standars Institute. Performance Standards for Antimicrobial Susceptibility Testing 2010. M100 - S20. Vol. 30 No. 1.

Quiroga M, Pegels, Peryra, M. Vergara. Antibiotic susceptibility patterns and prevalence of Group B streptococcus isolated from pregnant women in Misiones, Argentina. Brazilian Journal of Microbiology (2008) 39: 245-250

Abarzúa F, Arias A, García P y otros. Aumento de resistencia de Streptococcusagalactiae vaginal-anal en el tercer trimestre de gestación

a eritromicina y clindamicina al cabo de una década de tamizaje universal. Rev Chil Infect 2011; 28 (4): 334-337

Joachim A, Matee M I, Massawe F A, Lyamuya E F. Maternal and neonatal colonization of group B streptococcus at Muhimbili National Hospital in Dar es Salaam, Tanzania: prevalence, risk factors and antimicrobial resistance. BMC Public Health 2009; 9: 437.

Wu H M, Janapatla R P, Ho Y R, Hung K H, Wu C W, Yan J J, et al. Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan. Antimicrob Agents Chemother 2008; 52: 1888-90.

Simoes JA, Aroutcheva AA, Heimler I, Faro S. Antibiotic resistance patterns of group B streptococcal clinical isolates. Infect Dis ObstetGynecol 2004; 12: 1-8.

González JJ, Andreu A. Susceptibility of vertically transmitted Group B streptococci to antimicrobial agents. Multicenterstudy. EnfermInfeccMicrobiolClin. 2004 May; 22(5):286-91.

Valdes r, Enrique et al. Prevalencia de colonización por Streptococcus agalactiae(grupo B) durante el embarazo pesquisado en medio de cultivoselectivo. Rev. chil. obstet. ginecol. 2004, vol.69, n.2

ViegasCaetano J y col. Detección y caracterización de Streptococcusagalactiae en muestras para urocultivo. ActaBioquímClínLatinoam 2004;38 (4): 459-63

Metsvaht T, Oselin K, Ilmoja ML, Anier K, Lutsar I .Pharmacokinetics of penicillin g in very-low-birth-weight neonates. Antimicrob Agents Chemother. 2007 Jun; 51(6):1995-2000.

Download Citation

Published

How to Cite

the susceptibility profile of S. agalactiae isolated from vaginal cavity and perineal region from pregnant women in Medellín (Colombia)

Declaración de privacidad.

Keywords